• Profile
Close

Association of anticoagulant therapy with risk of fracture among patients with atrial fibrillation

JAMA Internal Medicine Feb 09, 2020

Lutsey PL, Norby FL, Ensrud KE, et al. - This comparative effectiveness cohort study was conducted to investigate the assumption that, among individuals with nonvalvular AF, the use of DOACs vs warfarin is correlated with a lower risk of incident fracture. The MarketScan administrative claims databases were applied to distinguish individuals with nonvalvular AF and who were prescribed oral anticoagulants between January 1, 2010, and September 30, 2015. A total of 167,275 individuals with AF were recruited in this study. Data were examined between February 27, 2019, and September 18, 2019. The use of DOACs—especially apixaban—compared with warfarin use was linked with lower fracture risk in this real-world population of 167,275 individuals with AF. These relationships were more noticeable among individuals with a diagnosis of osteoporosis. Given the potential adverse outcomes of warfarin on bone health, the results indicated that caution should be used when prescribing warfarin to individuals with AF at high risk of fracture.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay